Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance of a viral population and its individual intrahost variants during the first 48 hours of therapy.

Clinical pharmacology and therapeutics - 1 Jun 2014

Campo D S, Skums P, Dimitrova Z, Vaughan G, Forbi J C, Teo C G, Khudyakov Y, Lau D T-Y

Abstract excerpt

Using hepatitis C virus (HCV) and interferon (IFN) resistance as a proof of concept, we have devised a new method for calculating the effect of a drug on a viral population, as well as the resistance of the population's individual intrahost variants. By means of next-generation sequencing, HCV va...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polyethylene Glycols

Share to Population

Share to Real-Time Polymerase Chain Reaction

Share to Ribavirin

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 24488144
DOI: 10.1038/clpt.2014.20
PMCID: PMC4215939

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24488144-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance of a viral population and its individual intrahost variants during the first 48 hours of therapy.PMID 24488144Read ↗

Comparison of antiviral resistance across acute and chronic viral infections.Semantic proximity Read ↗

Antiviral drug resistance as an adaptive processSemantic proximity Read ↗

Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antivirals.Semantic proximity Read ↗

The emerging field of HCV drug resistanceSemantic proximity Read ↗

A translational study of resistance emergence using sequential direct-acting antiviral agents for hepatitis C using ultra-deep sequencing.Semantic proximity Read ↗

Drug resistance in antiviral therapy.Semantic proximity Read ↗

Rapid emergence of protease inhibitor resistance in hepatitis C virus.Semantic proximity Read ↗

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients.Semantic proximity Read ↗

Rational design and adaptive management of combination therapies for Hepatitis C virus infectionSemantic proximity Read ↗

Collateral effects of drug resistance evolution: explaining repeatability and directionality patternsSemantic proximity Read ↗

Exploring evolutionary trajectories of drug resistance.Semantic proximity Read ↗

Pre-existence and emergence of drug resistance in a generalized model of intra-host viral dynamics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.